Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.

"Potential conflict of interest: Drs. Luo and Schroth own stock in Illumina, Inc. Dr. Klenerman is a consultant for Pfizer."

"We thank the Wellcome Trust Integrative Physiology Initiative on Ion Channels (OXION) for funding a proportion of the microarray work. P. Klenerman and R. Narayan are supported by the Welcome Trust, The James Martin School for the 21st Century, the NIHR Biomedical Research Centre Programme (Oxford) and the NIH 1V19A1082630-01. S. Luo and G. Schroth are employed by Illumina, who kindly supplied materials and expertise for the RNA-Seq experiment. S. Woodhouse, S. Latham, R. Antrobus, B. Gangadharan, and N. Zitzmann were supported by the Oxford Glycobiology Institute. N. Zitzmann is a Senior Research Fellow of Linacre College, Oxford"